New partnership

Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies

Medis will be an exclusive partner for the commercialization of three innovative products in 9 different markets across the CEE region.

Exclusive Partnership

Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health

Medis has signed a long-term agreement with Salix for the commercialization of a new and innovative digestive health product in 11 different countries across...

Medis will Commercialize Orphan Drug NaMuscla® in Central and Eastern European Countries

Medis will initially focus on the commercialization of NaMuscla® in Croatia, Czech Republic, Hungary, Slovakia, and Slovenia.

We wish you a winning 2022

The Ode to the Winners was composed by Drago Ivanuša in November 2021 in honour of all the doctors and pharmacists who participate in the International Medis...

Satisfaction at Medis Remains High

The year 2021 is marked by high job satisfaction and high level of commitment to work. The vast majority of employees would be happy to recommend the Medis...

Ladiva Awarded for Innovation!

Ladiva is the only OTC plant-based medicine for relieving painful menstrual spasms.